MDT Relative Valuation
MDT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MDT is overvalued; if below, it's undervalued.
Historical Valuation
Medtronic PLC (MDT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 17.44 is considered Undervalued compared with the five-year average of 17.16. The fair price of Medtronic PLC (MDT) is between 115.83 to 140.28 according to relative valuation methord. Compared to the current price of 101.99 USD , Medtronic PLC is Undervalued By 11.95%.
Relative Value
Fair Zone
115.83-140.28
Current Price：101.99
11.95%
Undervalued
17.44
PE
1Y
3Y
5Y
Trailing
Forward
14.43
EV/EBITDA
Medtronic PLC. (MDT) has a current EV/EBITDA of 14.43. The 5-year average EV/EBITDA is 14.55. The thresholds are as follows: Strongly Undervalued below 10.62, Undervalued between 10.62 and 12.58, Fairly Valued between 16.51 and 12.58, Overvalued between 16.51 and 18.48, and Strongly Overvalued above 18.48. The current Forward EV/EBITDA of 14.43 falls within the Historic Trend Line -Fairly Valued range.
16.12
EV/EBIT
Medtronic PLC. (MDT) has a current EV/EBIT of 16.12. The 5-year average EV/EBIT is 16.17. The thresholds are as follows: Strongly Undervalued below 11.90, Undervalued between 11.90 and 14.03, Fairly Valued between 18.31 and 14.03, Overvalued between 18.31 and 20.45, and Strongly Overvalued above 20.45. The current Forward EV/EBIT of 16.12 falls within the Historic Trend Line -Fairly Valued range.
3.53
PS
Medtronic PLC. (MDT) has a current PS of 3.53. The 5-year average PS is 3.81. The thresholds are as follows: Strongly Undervalued below 2.33, Undervalued between 2.33 and 3.07, Fairly Valued between 4.55 and 3.07, Overvalued between 4.55 and 5.29, and Strongly Overvalued above 5.29. The current Forward PS of 3.53 falls within the Historic Trend Line -Fairly Valued range.
15.77
P/OCF
Medtronic PLC. (MDT) has a current P/OCF of 15.77. The 5-year average P/OCF is 15.67. The thresholds are as follows: Strongly Undervalued below 9.63, Undervalued between 9.63 and 12.65, Fairly Valued between 18.69 and 12.65, Overvalued between 18.69 and 21.70, and Strongly Overvalued above 21.70. The current Forward P/OCF of 15.77 falls within the Historic Trend Line -Fairly Valued range.
21.01
P/FCF
Medtronic PLC. (MDT) has a current P/FCF of 21.01. The 5-year average P/FCF is 20.25. The thresholds are as follows: Strongly Undervalued below 12.36, Undervalued between 12.36 and 16.31, Fairly Valued between 24.19 and 16.31, Overvalued between 24.19 and 28.13, and Strongly Overvalued above 28.13. The current Forward P/FCF of 21.01 falls within the Historic Trend Line -Fairly Valued range.
Medtronic PLC (MDT) has a current Price-to-Book (P/B) ratio of 2.69. Compared to its 3-year average P/B ratio of 2.23 , the current P/B ratio is approximately 20.65% higher. Relative to its 5-year average P/B ratio of 2.48, the current P/B ratio is about 8.62% higher. Medtronic PLC (MDT) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 4.42%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 4.16% , the current FCF yield is about -100.00% lower.
2.69
P/B
Median3y
2.23
Median5y
2.48
3.98
FCF Yield
Median3y
4.42
Median5y
4.16
Competitors Valuation Multiple
The average P/S ratio for MDT's competitors is 5.27, providing a benchmark for relative valuation. Medtronic PLC Corp (MDT) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 6.64%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MDT increased by 29.80% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 22.68 to 27.64.
The secondary factor is the Revenue Growth, contributed 6.64%to the performance.
Overall, the performance of MDT in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Medtronic PLC (MDT) currently overvalued or undervalued?
What is Medtronic PLC (MDT) fair value?
How does MDT's valuation metrics compare to the industry average?
What is the current P/B ratio for Medtronic PLC (MDT) as of Dec 05 2025?
What is the current FCF Yield for Medtronic PLC (MDT) as of Dec 05 2025?
What is the current Forward P/E ratio for Medtronic PLC (MDT) as of Dec 05 2025?